Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
The Sunday Read: The Real Cost of Labor’s NDIS Cuts - Podcast
The latest Full Story podcast, "Back to Back Barries: Can Labor’s ‘tough decisions’ save the NDIS?", examines the Australian Labor government’s plan to slash funding for the National Disability Insurance Scheme. The episode outlines a proposed $2.5 billion cut over four years, focusing on high‑cost participants and tighter eligibility. Experts and disability advocates discuss how the reductions could widen service gaps and strain providers. The discussion frames the cuts as a fiscal response to a growing federal deficit, raising questions about long‑term social outcomes.
‘He Needed Intensive Care and a Team of Specialists. He Got Me Instead’: An Outback Doctor on Treating Patients a...
A doctor stationed at a 20‑bed hospital in the remote Northern Territory describes the stark reality of providing acute care across a region the size of Norway for just 8,000 residents. Patients often arrive with life‑threatening conditions—heart, kidney or trauma—yet...
Scientists Transform Wool Into Bone Repair Material
Scientists at King’s College London have shown that keratin extracted from wool can act as a biodegradable scaffold for bone regeneration. In rat skull‑defect models, the wool‑based membranes guided new bone growth that was more organized and structurally similar to...
Dr. William Makis: Doctors Offer EUTHANASIA to COVID Jab Victims—“They Don’t Want Anything to Do With You”
Dr. William Makis, a Canadian oncologist now based in Florida, claims that patients who suffer injuries they attribute to COVID‑19 vaccines are being denied proper medical care and are instead offered medically assisted suicide in Canada. He cites a case...
Natural Compound Obakulactone Shows Therapeutic Potential for Rheumatoid Arthritis
Researchers have identified obakulactone, a natural tetracyclic triterpenoid from Phellodendri cortex, as a promising therapeutic for rheumatoid arthritis (RA). In a CFA‑induced rat model, oral dosing (50‑200 mg·kg⁻¹·d⁻¹) over 21 days markedly reduced joint swelling, restored cartilage integrity, and modulated immune...
Family Values Can Seed Physician Burnout Before Practice
Physician burnout is often inherited before it is experienced. Amna Shabbir, MD, an internal medicine physician and geriatrician, traces her own burnout not to medical school, residency, or the pandemic, but to the year she was born. Her mother was...
Nanophotonic Chips Finally Make the Proteome Visible
We sequence genomes and map transcriptomes with ease. Why is the proteome still invisible? Proteins are where biology actually happens. But until now, we have lacked the tools to read them at scale. @jendionne and her team are building nanophotonic chips that...
Rotavirus Cases in Children Are Rising, but a Highly Effective Vaccine Has Slashed Hospitalizations
Rotavirus infections in U.S. children are climbing earlier this season, with test positivity reaching nearly 8% in early 2026. Since the oral vaccine’s introduction in 2006, hospitalizations have fallen 80% and emergency‑room visits 57%, underscoring its effectiveness. However, vaccination coverage...
AI Helps Chemists Design Molecules Step by Step
Researchers at EPFL unveiled Synthegy, a new framework that pairs large language models with traditional retrosynthesis and mechanism‑prediction tools. By translating candidate pathways into text, the LLM evaluates each route against plain‑language user goals and scores its chemical plausibility. In...
Study Finds Different Types of Crystalloid Fluids Are Equally Effective for Pediatric Sepsis
A multinational trial involving more than 9,000 children with suspected septic shock found that balanced crystalloid fluids and 0.9% saline are equally effective at preventing major adverse kidney events within 30 days. MAKE30 occurred in 3.4% of the balanced‑fluid group...
Study: NY Cannabis Packaging Law Did Not Reduce Child Ingestions
New York’s 2023 child‑resistant packaging law for cannabis products failed to curb accidental pediatric ingestions, a study presented at the Pediatric Academic Societies meeting found. Researchers examined 174 cases from 2010 to 2025, noting a sharp rise in incidents after...
Platelet-to-HDL Ratio Linked to Eosinophils in Pediatric Asthma
A new study in Pediatric Research reveals a positive correlation between the platelet‑to‑HDL cholesterol ratio (PHR) and blood eosinophil counts in children with asthma. Analyzing a well‑characterized pediatric cohort, researchers found that higher PHR values align with elevated eosinophils, indicating...
Severe Infections Independently Amplify the Risk of Dementia Later in Life
Researchers analyzing Finland’s nationwide health registry found that severe infections requiring hospitalization increase the risk of later‑life dementia. After reviewing up to 21 years of records for 62,555 dementia patients and five matched controls each, they identified cystitis and unspecified...
Deuruxolitinib Demonstrates Consistent Efficacy, Early Hair Regrowth in Severe Alopecia Areata
Deuruxolitinib (Leqselvi), an oral JAK1/JAK2 inhibitor from Sun Pharma, demonstrated robust efficacy in two pooled Phase 3 trials (THRIVE‑AA1 and THRIVE‑AA2) involving 867 adults with severe alopecia areata. At 24 weeks, 31% of treated patients achieved a SALT score of 20...
MASH Cirrhosis Trials Lack Consistent End Points
A new systematic review of phase 2 and 3 trials for metabolic dysfunction‑associated steatohepatitis (MASH) cirrhosis finds that endpoint selection is highly variable, with most studies relying on histologic improvement and few incorporating patient‑centered outcomes. The analysis identified only nine eligible...
Wealth Boosts Health Spending, Not Necessarily Health Outcomes
Two important takeaways: 1. Health care is a superior good. As a country becomes richer, it will choose to spend more on health. 2. This tells you nothing about outcomes/efficiency. A country may spend a lot & still not get as high...
CAR Therapies Could Offer New HBV, HIV Treatments
A new systematic review in Frontiers in Medicine evaluates 43 studies of virus‑directed CAR‑T and CAR‑NK therapies for chronic hepatitis B and HIV. Preclinical data show significant reductions in HIV p24 antigen, HBV surface antigen, and viral DNA, while early...
Optimizing Neonatal Transport via Quality Improvement Metrics
Hospitals are deploying quality‑improvement (QI) metrics to streamline neonatal transport, focusing on real‑time data, standardized handoffs, and performance dashboards. Early pilots show transport times shrinking by roughly 20% and a 15% dip in transport‑related mortality. The initiative also trims redundant...
Why Local Care Matters for Peripheral Arterial Disease
Peripheral arterial disease (PAD) remains a leading cause of stroke, amputation and death, affecting more than 200 million people worldwide. Dr. Devin Zarkowsky argues that delivering PAD care locally—through office‑based procedures, portable imaging and minimally invasive techniques—dramatically improves outcomes and reduces...
New Trial Prevents Cognitive Decline in Older Cancer Patients
A multicentric randomized controlled trial in India, called GOCog, tested a culturally tailored multidomain intervention to prevent chemotherapy‑induced cognitive decline in patients aged 60 and older. The program combined cognitive training, physical activity, nutrition guidance, and psycho‑educational support, and was...
Mike Rockefeller's Podcast Democratizes Elite Healthcare Investment Insight
Super awesome that one of the most respected active healthcare investors, Mike Rockefeller (Co-CIO at Woodline and formerly a top Citadel PM) started a podcast interviewing healthcare CEOs. When I was a PM, I would occasionally share group meetings with Mike,...
Exercise Linked to Lower Mortality Risk in CKD
A new systematic review and meta‑analysis of 82 randomized trials involving 4,192 chronic kidney disease (CKD) patients found that regular physical exercise markedly lowers all‑cause mortality, cutting risk by 46% overall and by 55% among dialysis‑dependent patients. The analysis also...
Losing Weight Improves Heart Muscle Contraction in People with Obesity and Heart Failure
A Johns Hopkins‑led NIH study published in Science shows that severe obesity (BMI > 40) markedly weakens heart‑muscle cell contraction in patients with heart‑failure with preserved ejection fraction (HFpEF). The dysfunction is linked to excess phosphorylation of the contractile protein troponin‑I. In...
Personalised Treatment Plans Reverse Early Dementia Symptoms in New Study
A new study reported that personalised medical and lifestyle protocols reversed symptoms in people with early-stage dementia. The approach targets nutritional gaps, infections and environmental factors, offering a biohacking‑style route to cognitive improvement.
Children’s Antibiotic Use Soars with Medical Complexity
A new study of 2.36 million Medicaid children across 11 states found that kids with three or more complex chronic conditions filled antibiotic prescriptions at more than five times the rate of healthy peers and twice the rate of seniors. Overall,...
BIOOCUS Reports Breakthrough Dual CD19/BCMA CAR‑T Success in Refractory Myasthenia Gravis
BIOOCUS Medical Group announced that its autologous dual‑target CD19/BCMA CAR‑T therapy induced deep clinical remission in a 20‑year‑old patient with refractory Myasthenia Gravis. The treatment, delivered in November 2025, showed rapid CAR‑T expansion, a marked drop in autoantibodies, and resolution of...
Senseonics Rolls Out Eversense 365, First One‑Year CGM, Across Europe
Senseonics Holdings launched the Eversense 365 continuous glucose monitor in Europe, beginning with Sweden. The implantable sensor offers a 12‑month lifespan—double the previous six‑month model—and reduces calibration to once a week, promising a new standard for long‑term diabetes management.
VA’s $10 Billion Cerner EHR Rollout Stalls, Exposing Enterprise Migration Risks
Eight years after a $10 billion no‑bid contract was awarded, the Veterans Affairs department has installed Oracle‑Cerner’s electronic health‑record system at just 10 of its 1,400 hospitals. The stalled rollout has triggered patient‑safety alerts, a wave of clinician resignations, and bipartisan...
PE/PPE Proteins Drive Tuberculosis Drug Resistance
Researchers have identified the PE/PPE protein families as key drivers of drug resistance in Mycobacterium tuberculosis. Genetic analyses reveal that specific PE/PPE variants up‑regulate efflux pumps and alter cell‑wall permeability, reducing the efficacy of first‑line antibiotics such as isoniazid and...
PBMs' Formulary Tactics Drive Billion‑Dollar Patient Costs
The same companies you say are denying claims, are the ones you prop up buying access to formularies. Tell your members to stop being afraid of the PBMs and the insurance companies that own them, or they own. Your...
Every 1,000 Steps Cuts Mortality Risk by 15%
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis A 1000-step increment was associated with a 15% decreased risk of all-cause mortality... with significant benefits starting event at 2500/4000 steps/day. https://t.co/8d6VGnP0Dg https://t.co/f9h0D5dWlV
System C: Potential Acquirers
CVC Capital Partners is selling System C Healthcare, a UK health‑tech platform, via Arma Partners. The company, now valued at roughly £800 million ($1.0 billion) after growing EBITDA from £12 million to £46 million ($58 million) and revenue to £130 million ($165 million), combines acute‑hospital EPRs with...
Kidney Decline Skews Neurodegenerative Biomarker Levels; Ratios Help
Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of Ratios https://t.co/5TCkkyDxkM
Unified AI Healthcare Regulation Accelerates Patient Access
"50 competing standards cannot be the answer for a technology this consequential... many assume that regulation slows down transformative technology, but history suggests otherwise." Great piece by @HashemZikry calling for consistent regulatory guidance to **improve**, not impede, the solving of...
Chemed Corp Beats Q1 2026 Estimates, Raises Full-Year Outlook on VITAS Surge
Chemed Corp reported first‑quarter revenue of $657.5 million and adjusted EPS of $5.65, surpassing forecasts. The company raised its 2026 full‑year EPS guidance to $24.00‑$24.75, citing a 3.1% rise in VITAS hospice net patient revenue and a robust cash‑return program.
New AI Chatbot Uses Medical Protocols to Guide Patient Care Decisions.
UC San Diego researchers unveiled a multi‑agent AI chatbot that uses American Medical Association flowcharts to guide self‑triage. The system matches patient symptoms to protocol‑based questions, translating clinical language into lay terms. In over 30,000 simulated dialogues it chose the...
Capricorn Fund Sells $18.4 M of Waystar Stock, Highlighting Health‑Tech SaaS Valuation Concerns
Capricorn Fund Managers off‑loaded 692,554 Waystar shares worth $18.38 million in Q1 2026, reducing the healthcare‑SaaS provider to 0.17% of the fund’s U.S. equity portfolio. The sale comes as Waystar’s stock has fallen 32.5% over the past year, raising questions about...
Capitol Dispatch Weekend Digest
The Connecticut Senate approved a bill prohibiting private‑equity firms from acquiring or expanding control of state hospitals, effective October 2026. Simultaneously, the state’s insurance regulator fined the five largest health insurers for breaching mental‑health parity requirements. The state agricultural lab...
Medicare Practice Expense Cuts Will Hurt Patients
The Centers for Medicare & Medicaid Services released a final rule for the 2026 Medicare Physician Fee Schedule that trims practice‑expense inputs, lowering facility‑based physician payments by about 7%. The reduction does not reflect the true overhead costs independent clinicians...
Sanofi and Regeneron Win FDA Approvals as AbbVie Faces Rejection; Lilly Buys Kelonia
Sanofi and Regeneron received FDA approvals on Thursday, while AbbVie’s submission was turned down. In the same day, Eli Lilly announced a strategic acquisition of Kelonia, a gene‑therapy developer. The mixed regulatory outcomes and the deal highlight shifting dynamics in biotech...
The Step Count That Cuts Dementia Risk The Most (M)
A recent epidemiological study identified a specific daily step count that most effectively lowers the risk of Alzheimer’s disease. Participants who logged roughly 10,000 steps per day experienced up to a 30% reduction in dementia incidence compared with sedentary peers....
Misleading Review on E-Cigarettes Slammed
Health and academic experts in the UK have denounced a recent qualitative risk assessment that labeled nicotine‑based e‑cigarettes as “likely carcinogenic to humans.” They argue the review lacks robust epidemiological data and fails to compare vaping to smoking, making its...
CMS Posts January 2026 Medicaid/CHIP Enrollment Report: 75.3M, Down 4.2M Since December 2024
The Centers for Medicare & Medicaid Services released its January 2026 Medicaid and CHIP enrollment snapshot, showing 75.3 million total enrollees – 68.0 million in Medicaid and 7.2 million in CHIP. Adult Medicaid coverage accounts for 39.4 million, while children and CHIP participants total 35.9 million....
Thyroid Hormones Correlate
Associations of Thyroid Hormones and Resting Heart Rate in Patients Referred to Coronary Angiography https://t.co/aOvAW52tQ6
New Government Data Confirms Multiple Major Cancers Surged in Young Americans During the Mass mRNA Injection Campaign
The episode discusses newly released NIH National Cancer Institute data showing a 6.4% rise in overall cancer incidence among Americans under 50 between 2021 and 2023, with sharp increases in colorectal, brain, ovarian, small‑intestine, stomach, and breast cancers. Host and...
Influenza Pioneer Nancy Cox Passes, Legacy in Global Surveillance
The world of influenza science has lost one of its giants. Nancy Cox, who led #CDC's flu division for years & worked assiduously to improve global flu surveillance, died Thursday. I learned a ton from Nancy Cox. RIP. https://t.co/vNBuYpFSpU
AIDS Creeps Back in Parts of Zambia, a Year After U.S. Cuts to H.I.V. Assistance
A resurgence of AIDS cases has emerged in Zambia after the Trump administration slashed U.S. HIV assistance, dismantling key prevention programs. In the mining town of Mpongwe, new infections surged to 28 per month in early 2026, far exceeding the...
Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices
Implicity announced that its new manufacturer‑agnostic, cloud‑based AI algorithm reduced false‑positive alerts in AI‑equipped implantable loop recorders by 61.6% while preserving 98.3% sensitivity. The findings, presented at the Heart Rhythm Society 2026 meeting, stem from an analysis of 483 episodes...
'Eventually, It Becomes You': Inventors of New 'Living' Knee Replacement Describe Why This Tech Is Desperately Needed and How It...
Columbia University and the University of Missouri are developing NOVAKnee, a 3D‑printed, biodegradable knee implant seeded with stem‑cell‑derived bone and cartilage. The scaffold is designed to dissolve as new tissue forms, potentially offering a longer‑lasting solution than metal‑plastic prostheses that...
New Study Reveals That Daytime Naps May Be A Sign Of Serious Health Problems
New research published in JAMA Network, analyzing nearly 1,300 adults, finds that daytime naps lasting an hour or more are associated with higher all‑cause mortality, while short naps under an hour show no such risk. The study suggests the link...